fermentek

 

Fermentek homepage
about
products
contact us

Resources

Sullivan JA, Grummer MA, Yi FX, Bird IM.

Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.

Endocrinology. 2006 May;147(5):2442-57

Department of Obstetrics and Gynecology, Perinatal Research Laboratories, University of Wisconsin, Madison, 53715, USA.
During pregnancy, vascular remodeling and vasoactive agents such as nitric oxide (NO) increase blood flow to the uteroplacental unit. Using our uterine artery endothelial cell (UAEC) culture model, based on cells from pregnant (P-UAEC) and nonpregnant (NP-UAEC) ewes, we investigate the relative physiological roles of Ca(2+) vs. kinase in the regulation of endothelial NO synthase (eNOS) activity. When Ca(2+) mobilization is fully inhibited using inhibitors of phospholipase C (PLC) (U73122) and the inositol triphosphate (IP3) receptor (IP3-R) (2-APB), significant residual eNOS activity remains in both P- and NP-UAEC. No change in ATP-stimulated ERK2, Akt, or eNOS phosphorylation is observed with U73122 (0.01-1 microM) or 2-APB (1-50 microM). The MAPK kinase (MEK) 1/2 inhibitor U0126 (10 microM) did not alter ATP-stimulated eNOS activity in P-UAEC, but potentiated the ATP response in NP-UAEC. Using two phosphatidylinositol 3-kinase (PI3-K) inhibitors, we observed no effect with LY294002 (10 microM) on eNOS activity in P- and NP-UAEC, but wortmannin (10 microM) inhibited both P- and NP-UAEC eNOS activation. Expression of constitutively active Akt (ca-Akt) in UAEC resulted in slight elevation of basal eNOS activity, but relative ATP-stimulated eNOS activation was not altered by ca-Akt. Wortmannin continued to inhibit eNOS activation by ATP in the presence of ca-Akt; LY294002 still had no inhibitory effect. Our data indicate both [Ca(2+)](i) and multiple kinases are involved in the regulation of eNOS activity in our model. We report that pregnancy adaptation of eNOS activation includes the reduced sensitivity to ERK-mediated attenuation of eNOS activity and enhanced stimulation of eNOS activity through a wortmannin-sensitive, LY294002-insensitive, Akt-independent mechanism.
 

 

back to product page

 
fermentek  

Sitemap
Home Products Hebrew About us ISO GMP/API Mad cow GMO | Sales policy Receiving RFQ OrderingContact webmaster Ask scientist Contact sales  |
Privacy About website Copyright

Products
7AAD 17AAG 17DMAG A23187, 4-Bromo A23187, Ca/ Mg salt A23187 (free acid) Actinomycin D Aflatoxin B1 Aflatoxin B2 Aflatoxin G1 Aflatoxin G2 Aflatoxin M1 Aflatoxin M2 Alamethicin Anisomycin Apicidin Aphidicolin Ascomycin Bafilomycin A1 Brefeldin A castanospermine Cerulenin Chelerythrine Chromomycin A3 Citrinin Cyclopiazonic acid Cytochalasin A Cytochalasin B Cytochalasin C Cytochalasin D Cytochalasin E Dihidrocytochalasin Deoxynivalenol FK506 Forskolin Fumagillin Fumonisin B1 Fumonisin B2 Geldanamycin Genistein Gliotoxin Hypericin HT2 toxin Ionomycin Ca K252A K252B KT5720 KT5823 Leptomycin B Mithramycin A Mitomycin C Moniliformin Mycophenolic Myriocin Nigericin Nonactin Ochratoxin A Oligomycin Oligomycin A Oligomycin B Parthenolide Patulin Paxilline Penicillic acid Penitrem A PKC412 Puromycin Puromycin AN Radicicol Rapamycin Staurosporine Sirolimus Sterigmatocystin T2 toxin Taxol Tentoxin Thapsigargin Thiolutin Triacsin Trichostatin Tunicamycin Valinomycin Verruculogen Vomitoxin Withaferin A Wortmannin Zearalenone


unique visitor counter
 
Company's eMail: 

Anti-spam measures have been taken here. Please copy this address into your eMail software. We are sorry for the inconvenience.

Mail Address:

Yatziv 25, POB 47120, Jerusalem 97800 Israel

Phone: 972 2 5853953

Fax: 972 2 5853943


--

ZZZ from Fermentek for sale